Sign in Subscribe
Biotechnology

The Biotech Growth Trust PLC Announces Market Purchase of Its Own Shares

Strategic Insights

— 1 min read

The Biotech Growth Trust PLC has disclosed that it has acquired a total of 155,562 of its own Ordinary shares as part of its authority to make market purchases of its shares up to a maximum of 4,255,299. This move is aimed at reducing the Company's issued share capital and increasing the proportion of shares held by existing shareholders. The shares were purchased at a price of 706.68 pence per share, which will be canceled immediately.

Key Takeaways:

  • The Biotech Growth Trust PLC has executed a market purchase of its own shares, totaling 155,562 Ordinary shares.
  • The purchase is part of the Company's authority to make market purchases of its shares up to 4,255,299.
  • The shares were acquired at a price of 706.68 pence per share and will be canceled immediately.
  • The total number of Ordinary shares in issue has decreased to 26,373,965, following this transaction.
  • The Company does not hold any Ordinary shares in treasury.
  • The figure of 26,373,965 may be used as the denominator for calculating voting rights and required notifications under the FCA's Disclosure Guidance and Transparency Rules by shareholders.

Statistics:

  • Total shares purchased: 155,562
  • Total maximum shares to be purchased: 4,255,299
  • Price per share: 706.68 pence
  • Total number of Ordinary shares in issue: 26,373,965
  • Percentage decrease in issued share capital: 0.59% (based on the maximum shares to be purchased)

Sources:

  • PR Newswire For immediate release, 16 May 2025

Read more